{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:19:18Z","timestamp":1770351558813,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>There are countless possibilities for drug combinations, which makes it expensive and time-consuming to rely solely on clinical trials to determine the effects of each possible drug combination. In order to screen out the most effective drug combinations more quickly, scholars began to apply machine learning to drug combination prediction. However, most of them are of low interpretability. Consequently, even though they can sometimes produce high prediction accuracy, experts in the medical and biological fields can still not fully rely on their judgments because of the lack of knowledge about the decision-making process.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Related work<\/jats:title>\n                <jats:p>Decision trees and their ensemble algorithms are considered to be suitable methods for pharmaceutical applications due to their excellent performance and good interpretability. We review existing decision trees or decision tree ensemble algorithms in the medical field and point out their shortcomings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>This study proposes a decision stump (DS)-based solution to extract interpretable knowledge from data sets. In this method, a set of DSs is first generated to selectively form a decision tree (DST). Different from the traditional decision tree, our algorithm not only enables a partial exchange of information between base classifiers by introducing a stump exchange method but also uses a modified Gini index to evaluate stump performance so that the generation of each node is evaluated by a global view to maintain high generalization ability. Furthermore, these trees are combined to construct an ensemble of DST (EDST).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Experiment<\/jats:title>\n                <jats:p>The two-drug combination data sets are collected from two cell lines with three classes (additive, antagonistic and synergistic effects) to test our method. Experimental results show that both our DST and EDST perform better than other methods. Besides, the rules generated by our methods are more compact and more accurate than other rule-based algorithms. Finally, we also analyze the extracted knowledge by the model in the field of bioinformatics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The novel decision tree ensemble model can effectively predict the effect of drug combination datasets and easily obtain the decision-making process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-023-05453-3","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T14:02:56Z","timestamp":1693317776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["EDST: a decision stump based ensemble algorithm for synergistic drug combination prediction"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[]},{"given":"Lianlian","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Kunhong","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Song","family":"He","sequence":"additional","affiliation":[]},{"given":"Xiaochen","family":"Bo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"issue":"6","key":"5453_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, Zhao S. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463\u201377.","journal-title":"Nat Rev Drug Discov"},{"key":"5453_CR2","doi-asserted-by":"crossref","unstructured":"Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, van\u00a0der Meer D, Yang W, Beck A, Mironenko T, Hall C, Hall J, Mali I, Richardson L, Tolley C, Morris J, Thomas F, Lleshi E, Aben N, Benes CH, Bertotti A, Trusolino L, Wessels L, Garnett MJ. Effective drug combinations in breast, colon and pancreatic cancer cells. Nature 2022;603(7899):166+.","DOI":"10.1038\/s41586-022-04437-2"},{"issue":"5","key":"5453_CR3","doi-asserted-by":"publisher","first-page":"e1007068","DOI":"10.1371\/journal.pcbi.1007068","volume":"15","author":"S Qian","year":"2019","unstructured":"Qian S, Liang S, Yu H. Leveraging genetic interactions for adverse drug-drug interaction prediction. PLOS Comput Biol. 2019;15(5):e1007068.","journal-title":"PLOS Comput Biol"},{"issue":"W1","key":"5453_CR4","doi-asserted-by":"publisher","first-page":"W43","DOI":"10.1093\/nar\/gkz337","volume":"47","author":"B Zagidullin","year":"2019","unstructured":"Zagidullin B, Aldahdooh J, Zheng S, Wang W, Wang Y, Saad J, Malyutina A, Jafari M, Tanoli Z, Pessia A, Tang J. Drugcomb: an integrative cancer drug combination data portal. Nucleic Acids Res. 2019;47(W1):W43-51.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5453_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41597-022-01360-z","volume":"9","author":"G Shtar","year":"2022","unstructured":"Shtar G, Azulay L, Nizri O, Rokach L, Shapira B. CDCDB: a large and continuously updated drug combination database. Sci Data. 2022;9(1):263.","journal-title":"Sci Data"},{"issue":"10","key":"5453_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btaa826","volume":"37","author":"DJ Wooten","year":"2021","unstructured":"Wooten DJ, Albert R. Synergy: a python library for calculating, analyzing and visualizing drug combination synergy. Bioinformatics. 2021;37(10):1473\u20134.","journal-title":"Bioinformatics"},{"issue":"W1","key":"5453_CR7","doi-asserted-by":"publisher","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","volume":"48","author":"A Ianevski","year":"2020","unstructured":"Ianevski A, Giri AK, Aittokallio T. Synergyfinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 2020;48(W1):W488\u201393.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"5453_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","volume":"20","author":"S Zheng","year":"2022","unstructured":"Zheng S, Wang W, Aldahdooh J, Malyutina A, Shadbahr T, Tanoli Z, Pessia A, Tang J. Synergyfinder plus: toward better interpretation and annotation of drug combination screening datasets. Genomics Proteomics Bioinform. 2022;20(3):587\u201396.","journal-title":"Genomics Proteomics Bioinform"},{"issue":"1","key":"5453_CR9","doi-asserted-by":"publisher","first-page":"bbab355","DOI":"10.1093\/bib\/bbab355","volume":"23","author":"L Wu","year":"2022","unstructured":"Wu L, Wen Y, Leng D, Zhang Q, Dai C, Wang Z, Liu Z, Yan B, Zhang Y, Wang J, He S, Bo X. Machine learning methods, databases and tools for drug combination prediction. Brief Bioinform. 2022;23(1):bbab355.","journal-title":"Brief Bioinform"},{"issue":"6","key":"5453_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/bib\/bbac427","volume":"23","author":"S Chen","year":"2022","unstructured":"Chen S, Li T, Yang L, Zhai F, Jiang X, Xiang R, Ling G. Artificial intelligence-driven prediction of multiple drug interactions. Brief Bioinform. 2022;23(6):247.","journal-title":"Brief Bioinform"},{"key":"5453_CR11","doi-asserted-by":"publisher","first-page":"104270","DOI":"10.1016\/j.chemolab.2021.104270","volume":"212","author":"SM Hasan Mahmud","year":"2021","unstructured":"Hasan Mahmud SM, Chen W, Jahan H, Liu Y, Mamun Hasan SM. Dimensionality reduction based multi-kernel framework for drug-target interaction prediction. Chemom Intell Lab Syst. 2021;212:104270.","journal-title":"Chemom Intell Lab Syst"},{"issue":"1, SI","key":"5453_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/bib\/bbz157","volume":"22","author":"M Bagherian","year":"2021","unstructured":"Bagherian M, Sabeti E, Wang K, Sartor MA, Nikolovska-Coleska Z, Najarian K. Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Brief Bioinform. 2021;22(1, SI):247\u201369.","journal-title":"Brief Bioinform"},{"issue":"1","key":"5453_CR13","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1038\/s41467-020-19950-z","volume":"11","author":"H Julkunen","year":"2020","unstructured":"Julkunen H, Cichonska A, Gautam P, Szedmak S, Douat J, Pahikkala T, Aittokallio T, Rousu J. Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects. Nat Commun. 2020;11(1):6136.","journal-title":"Nat Commun"},{"key":"5453_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmpb.2018.11.002","volume":"168","author":"J-Y Shi","year":"2019","unstructured":"Shi J-Y, Li J-X, Mao K-T, Cao J-B, Lei P, Lu H-M, Yiu S-M. Predicting combinative drug pairs via multiple classifier system with positive samples only. Comput Methods Programs Biomed. 2019;168:1\u201310.","journal-title":"Comput Methods Programs Biomed"},{"key":"5453_CR15","doi-asserted-by":"crossref","unstructured":"Song F, Tan S, Dou Z, Liu X, Ma X. Predicting combinations of drugs by exploiting graph embedding of heterogeneous networks. BMC Bioinform. 2022;23(SUPPL 1, 1, SI).","DOI":"10.1186\/s12859-022-04567-4"},{"issue":"9","key":"5453_CR16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","volume":"34","author":"K Preuer","year":"2018","unstructured":"Preuer K, Lewis RPI, Hochreiter S, Bender A, Bulusu KC, Klambauer G. Deepsynergy: predicting anti-cancer drug synergy with deep learning. Bioinformatics. 2018;34(9):1538\u201346.","journal-title":"Bioinformatics"},{"issue":"4","key":"5453_CR17","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1109\/TCBB.2021.3086702","volume":"19","author":"HI Kuru","year":"2022","unstructured":"Kuru HI, Tastan O, Ercument CA. Matchmaker: a deep learning framework for drug synergy prediction. IEEE-ACM Trans Computat Biol Bioinform. 2022;19(4):2334\u201344.","journal-title":"IEEE-ACM Trans Computat Biol Bioinform"},{"issue":"6","key":"5453_CR18","doi-asserted-by":"publisher","first-page":"e1007129","DOI":"10.1371\/journal.pcbi.1007129","volume":"15","author":"I Lee","year":"2019","unstructured":"Lee I, Keum J, Nam H. DeepConv-DTI: prediction of drug-target interactions via deep learning with convolution on protein sequences. PLOS Comput Biol. 2019;15(6):e1007129.","journal-title":"PLOS Comput Biol"},{"issue":"2","key":"5453_CR19","doi-asserted-by":"publisher","first-page":"e1008653","DOI":"10.1371\/journal.pcbi.1008653","volume":"17","author":"Q Liu","year":"2021","unstructured":"Liu Q, Xie L. TranSynergy: mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations. PLOS Comput Biol. 2021;17(2):e1008653.","journal-title":"PLOS Comput Biol"},{"key":"5453_CR20","doi-asserted-by":"crossref","unstructured":"Yang Z, Tong K, Jin S, Wang S, Yang C, Jiang F. CNN-SIAM: multimodal Siamese CNN-based deep learning approach for drug-drug interaction prediction. BMC Bioinform. 2023;24(1).","DOI":"10.1186\/s12859-023-05242-y"},{"issue":"5","key":"5453_CR21","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1158\/1541-7786.MCR-21-0735","volume":"20","author":"Y-C Tang","year":"2022","unstructured":"Tang Y-C, Gottlieb A. Synpathy: Predicting drug synergy through drug-associated pathways using deep learning. Mol Cancer Res. 2022;20(5):762\u20139.","journal-title":"Mol Cancer Res"},{"key":"5453_CR22","doi-asserted-by":"crossref","unstructured":"Xu M, Zhao X, Wang J, Feng W, Wen N, Wang C, Wang J, Liu Y, Zhao L. Dffndds: prediction of synergistic drug combinations with dual feature fusion networks. J Cheminform. 2023;15(1).","DOI":"10.1186\/s13321-023-00690-3"},{"issue":"12","key":"5453_CR23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/17460441.2018.1538208","volume":"13","author":"V Schoening","year":"2018","unstructured":"Schoening V, Hammann F. How far have decision tree models come for data mining in drug discovery? Expert Opin Drug Discov. 2018;13(12):1067\u20139.","journal-title":"Expert Opin Drug Discov."},{"key":"5453_CR24","doi-asserted-by":"crossref","unstructured":"Deelder W, Napier G, Campino S, Palla L, Phelan J, Clark TG. A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in mycobacterium tuberculosis. BMC Genomics. 2022;23(1).","DOI":"10.1186\/s12864-022-08291-4"},{"key":"5453_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cmpb.2017.02.001","volume":"141","author":"M Tayefi","year":"2017","unstructured":"Tayefi M, Tajfard M, Saffar S, Hanachi P, Amirabadizadeh AR, Esmaeily H, Taghipour A, Ferns GA, Moohebati M, Ghayour-Mobarhan M. HS-CRP is strongly associated with coronary heart disease (CHD): a data mining approach using decision tree algorithm. Comput Methods Programs Biomed. 2017;141:105\u20139.","journal-title":"Comput Methods Programs Biomed"},{"issue":"4","key":"5453_CR26","doi-asserted-by":"publisher","first-page":"e2818","DOI":"10.1002\/btpr.2818","volume":"35","author":"H Narayanan","year":"2019","unstructured":"Narayanan H, Sokolov M, Butte A, Morbidelli M. Decision Tree-PLS (DT-PLS) algorithm for the development of process: specific local prediction models. Biotechnol Prog. 2019;35(4):e2818.","journal-title":"Biotechnol Prog"},{"key":"5453_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jconrel.2023.06.040","volume":"360","author":"DM Azagury","year":"2023","unstructured":"Azagury DM, Gluck BF, Harris Y, Avrutin Y, Niezni D, Sason H, Shamay Y. Prediction of cancer nanomedicines self-assembled from meta-synergistic drug pairs. J Control Release. 2023;360:418\u201332.","journal-title":"J Control Release"},{"issue":"3","key":"5453_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1109\/TCBB.2019.2952102","volume":"18","author":"H Lu","year":"2021","unstructured":"Lu H, Gao H, Ye M, Wang X. A hybrid ensemble algorithm combining adaboost and genetic algorithm for cancer classification with gene expression data. IEEE-ACM Trans Comput Biol Bioinform. 2021;18(3):863\u201370.","journal-title":"IEEE-ACM Trans Comput Biol Bioinform"},{"issue":"6","key":"5453_CR29","doi-asserted-by":"publisher","first-page":"bbab275","DOI":"10.1093\/bib\/bbab275","volume":"22","author":"Q An","year":"2021","unstructured":"An Q, Yu L. A heterogeneous network embedding framework for predicting similarity-based drug-target interactions. Brief Bioinform. 2021;22(6):bbab275.","journal-title":"Brief Bioinform"},{"key":"5453_CR30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fgene.2019.00459","volume":"10","author":"P Xuan","year":"2019","unstructured":"Xuan P, Sun C, Zhang T, Ye Y, Shen T, Dong Y. Gradient boosting decision tree-based method for predicting interactions between target genes and drugs. Front Genet. 2019;10:459.","journal-title":"Front Genet"},{"issue":"3","key":"5453_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/cancers15030625","volume":"15","author":"J Ma","year":"2023","unstructured":"Ma J, Bo Z, Zhao Z, Yang J, Yang Y, Li H, Yang Y, Wang J, Su Q, Wang J, Chen K, Yu Z, Wang Y, Chen G. Machine learning to predict the response to Lenvatinib combined with transarterial chemoembolization for unresectable hepatocellular carcinoma. Cancers. 2023;15(3):625.","journal-title":"Cancers"},{"key":"5453_CR32","doi-asserted-by":"crossref","unstructured":"Moghadas-Dastjerdi H, Rahman S-E-TH, Sannachi L, Wright FC, Gandhi S, Trudeau ME, Sadeghi-Naini A, Czarnota GJ. Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning. Transl Oncol. 2021;14(10).","DOI":"10.1016\/j.tranon.2021.101183"},{"key":"5453_CR33","doi-asserted-by":"crossref","unstructured":"Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, Lahr DL, Hirschman JE, Liu Z, Donahue M, Julian B, Khan M, Wadden D, Smith IC, Lam D, Liberzon A, Toder C, Bagul M, Orzechowski M, Enache OM, Piccioni F, Johnson SA, Lyons NJ, Berger AH, Shamji AF, Brooks AN, Vrcic A, Flynn C, Rosains J, Takeda DY, Hu R, Davison D, Lamb J, Ardlie K, Hogstrom L, Greenside P, Gray NS, Clemons PA, Silver S, Wu X, Zhao W-N, Read-Button W, Wu X, Haggarty SJ, Ronco LV, Boehm JS, Schreiber SL, Doench JG, Bittker JA, Root DE, Wong B, Golub TR. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437+.","DOI":"10.1016\/j.cell.2017.10.049"},{"issue":"5795","key":"5453_CR34","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J-P, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES, Golub TR. The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313(5795):1929\u201335.","journal-title":"Science"},{"issue":"3","key":"5453_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40257-018-0414-1","volume":"20","author":"D Meng","year":"2019","unstructured":"Meng D, Carvajal RD. Kit as an oncogenic driver in melanoma: an update on clinical development. Am J Clin Dermatol. 2019;20(3):315\u201323.","journal-title":"Am J Clin Dermatol"},{"key":"5453_CR36","doi-asserted-by":"crossref","unstructured":"Dang L, Wang Y, Shi C, Liao M, Sun Z, Fang S. A potential tumor suppressor gene named mir-508-5p inhibited the proliferation and invasion of human melanoma cells by targeting kit. Technol Cancer Res Treatment 2020;19.","DOI":"10.1177\/1533033820951801"},{"issue":"4","key":"5453_CR37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/cancers14040928","volume":"14","author":"K Ben Arfi","year":"2022","unstructured":"Ben Arfi K, Schneider C, Bennasroune A, Bouland N, Wolak-Thierry A, Collin G, Le Cuong C, Toussaint K, Hachet C, Lehrter V, Dedieu S, Bouche O, Morjani H, Boulagnon-Rombi C, Appert-Collin A. Discoidin domain receptor 1 expression in colon cancer: roles and prognosis impact. Cancers. 2022;14(4):928.","journal-title":"Cancers"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-023-05453-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T19:04:01Z","timestamp":1700334241000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-023-05453-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5453"],"URL":"https:\/\/doi.org\/10.1186\/s12859-023-05453-3","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"None of the authors have any conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"325"}}